1. Home
  2. Analysis
  3. Prednisone
  4. Arcapta-neohaler

Prednisone and Arcapta neohaler drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prednisone (prednisone) and Arcapta neohaler (indacaterol maleate). Common drug interactions include dyspnoea among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people have when they take Prednisone and Arcapta neohaler. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Prednisone?

Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. eHealthMe is studying from 636,827 Prednisone users. Check the latest studies of Prednisone.

What is Arcapta neohaler?

Arcapta neohaler has active ingredients of indacaterol maleate. eHealthMe is studying from 104 Arcapta neohaler users. Check the latest studies of Arcapta neohaler.

On Jul, 09, 2026

11 people who take Prednisone and Arcapta neohaler together, and have interactions are studied.

Prednisone and Arcapta neohaler drug interactions.

What are the common drug interactions of Prednisone and Arcapta Neohaler, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Skin ulcer
  3. Weight increased
  4. Blood pressure increased
  5. Death
  6. Dry skin
  7. Extrasystoles
  8. Heart rate irregular
  9. Infection
  10. Oropharyngeal pain

male:

  1. Abdominal distension
  2. Fractured coccyx (fracture tail bone)
  3. Hospitalisation
  4. Loss of consciousness
  5. Renal failure (kidney dysfunction)
  6. Sinus disorder (disease of sinus)
  7. Urine output decreased

What are the common drug interactions of Prednisone and Arcapta Neohaler, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Dyspnoea (difficult or laboured respiration)
  2. Weight increased

60+:

  1. Fractured coccyx (fracture tail bone)
  2. Hospitalisation
  3. Loss of consciousness

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 5 people, 45.45%
  2. Osteoporosis (bones weak and more likely to break): 1 person, 9.09%
  3. Asthma: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Prednisone and Arcapta neohaler?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Prednisone and Arcapta neohaler:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prednisone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Arcapta neohaler:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prednisone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Arcapta neohaler and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on prednisone and indacaterol maleate (the active ingredients of Prednisone and Arcapta neohaler, respectively), and Prednisone and Arcapta neohaler (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.